Post-kala-azar dermal leishmaniasis due to Leishmania infantum in an HIV-negative patient treated with miltefosine
Post-kala-azar dermal leishmaniasis due to Leishmania infantum in an HIV-negative patient is very infrequent and this case highlights how it can be associated to other types of immunosuppression. Moreover, this case reports an effective therapeutic option with miltefosine, which can be very useful d...
Gespeichert in:
Veröffentlicht in: | Journal of travel medicine 2022-11, Vol.29 (7) |
---|---|
Hauptverfasser: | , , , , , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | |
---|---|
container_issue | 7 |
container_start_page | |
container_title | Journal of travel medicine |
container_volume | 29 |
creator | Monge-Maillo, Begoña Norman, Francesca F Chamorro-Tojeiro, Sandra Gioia, Francesca Pérez-Molina, José-Antonio Chicharro, Carmen Moreno, Javier López-Vélez, Rogelio |
description | Post-kala-azar dermal leishmaniasis due to Leishmania infantum in an HIV-negative patient is very infrequent and this case highlights how it can be associated to other types of immunosuppression. Moreover, this case reports an effective therapeutic option with miltefosine, which can be very useful due to the scarce experience reported. |
doi_str_mv | 10.1093/jtm/taab169 |
format | Article |
fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_2584016995</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><oup_id>10.1093/jtm/taab169</oup_id><sourcerecordid>2823856032</sourcerecordid><originalsourceid>FETCH-LOGICAL-c385t-630a3914bd82e94f620b674819703d1d376d3e26fe7e2f05695ad0fef9f405163</originalsourceid><addsrcrecordid>eNp9kUtrHDEQhEVIiF855R4EgWAIY-sx0khHY5LYsGAfHF-H3lUr1npGs5Y0MfGvt8JufMjBpy6aj6KoIuQjZyecWXm6LuNpAVhybd-Qfd4x0xjJ1NuquVUNt0bskYOc14wxYYR4T_Zkq7VRyuyTdD3l0tzDAA08QaIO0wgDHTDkuxFigBwydTPSMtHFy5OG6CGWeayCQqQXl7dNxF9Qwm-km3owFloSQkFHH0O5o2MYCvoph4hH5J2HIeOH3T0kP79_uzm_aBZXPy7PzxbNShpVGi0ZSMvbpTMCbeu1YEvdtYbbjknHney0kyi0xw6FZ0pbBY559Na3THEtD8nx1neTpocZc-nHkFc4DBBxmnMvlGlZLc2qin7-D11Pc4o1XV8bq3E0k6JSX7fUKk05J_T9JoUR0p-es_7vFH2dot9NUelPO895OaJ7Yf91X4EvW2CaN686PQPLwJKx</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2823856032</pqid></control><display><type>article</type><title>Post-kala-azar dermal leishmaniasis due to Leishmania infantum in an HIV-negative patient treated with miltefosine</title><source>Oxford University Press Journals All Titles (1996-Current)</source><source>MEDLINE</source><source>Alma/SFX Local Collection</source><creator>Monge-Maillo, Begoña ; Norman, Francesca F ; Chamorro-Tojeiro, Sandra ; Gioia, Francesca ; Pérez-Molina, José-Antonio ; Chicharro, Carmen ; Moreno, Javier ; López-Vélez, Rogelio</creator><creatorcontrib>Monge-Maillo, Begoña ; Norman, Francesca F ; Chamorro-Tojeiro, Sandra ; Gioia, Francesca ; Pérez-Molina, José-Antonio ; Chicharro, Carmen ; Moreno, Javier ; López-Vélez, Rogelio</creatorcontrib><description>Post-kala-azar dermal leishmaniasis due to Leishmania infantum in an HIV-negative patient is very infrequent and this case highlights how it can be associated to other types of immunosuppression. Moreover, this case reports an effective therapeutic option with miltefosine, which can be very useful due to the scarce experience reported.</description><identifier>ISSN: 1195-1982</identifier><identifier>EISSN: 1708-8305</identifier><identifier>DOI: 10.1093/jtm/taab169</identifier><identifier>PMID: 34668558</identifier><language>eng</language><publisher>England: Oxford University Press</publisher><subject>Antifungal agents ; Antiprotozoal Agents - therapeutic use ; Case reports ; Diabetes ; HIV ; HIV Infections - complications ; HIV Infections - drug therapy ; Human immunodeficiency virus ; Humans ; Immunosuppression ; Leishmania infantum ; Leishmaniasis ; Leishmaniasis, Cutaneous - diagnosis ; Leishmaniasis, Cutaneous - drug therapy ; Leishmaniasis, Visceral - diagnosis ; Leishmaniasis, Visceral - drug therapy ; Miltefosine ; Phosphorylcholine - therapeutic use ; Vector-borne diseases</subject><ispartof>Journal of travel medicine, 2022-11, Vol.29 (7)</ispartof><rights>The Author(s) 2021. Published by Oxford University Press on behalf of International Society of Travel Medicine. All rights reserved. For permissions, please e-mail: journals.permissions@oup.com 2021</rights><rights>The Author(s) 2021. Published by Oxford University Press on behalf of International Society of Travel Medicine. All rights reserved. For permissions, please e-mail: journals.permissions@oup.com</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c385t-630a3914bd82e94f620b674819703d1d376d3e26fe7e2f05695ad0fef9f405163</citedby><cites>FETCH-LOGICAL-c385t-630a3914bd82e94f620b674819703d1d376d3e26fe7e2f05695ad0fef9f405163</cites><orcidid>0000-0003-0960-1630 ; 0000-0003-0336-7767</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,776,780,1578,27901,27902</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/34668558$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Monge-Maillo, Begoña</creatorcontrib><creatorcontrib>Norman, Francesca F</creatorcontrib><creatorcontrib>Chamorro-Tojeiro, Sandra</creatorcontrib><creatorcontrib>Gioia, Francesca</creatorcontrib><creatorcontrib>Pérez-Molina, José-Antonio</creatorcontrib><creatorcontrib>Chicharro, Carmen</creatorcontrib><creatorcontrib>Moreno, Javier</creatorcontrib><creatorcontrib>López-Vélez, Rogelio</creatorcontrib><title>Post-kala-azar dermal leishmaniasis due to Leishmania infantum in an HIV-negative patient treated with miltefosine</title><title>Journal of travel medicine</title><addtitle>J Travel Med</addtitle><description>Post-kala-azar dermal leishmaniasis due to Leishmania infantum in an HIV-negative patient is very infrequent and this case highlights how it can be associated to other types of immunosuppression. Moreover, this case reports an effective therapeutic option with miltefosine, which can be very useful due to the scarce experience reported.</description><subject>Antifungal agents</subject><subject>Antiprotozoal Agents - therapeutic use</subject><subject>Case reports</subject><subject>Diabetes</subject><subject>HIV</subject><subject>HIV Infections - complications</subject><subject>HIV Infections - drug therapy</subject><subject>Human immunodeficiency virus</subject><subject>Humans</subject><subject>Immunosuppression</subject><subject>Leishmania infantum</subject><subject>Leishmaniasis</subject><subject>Leishmaniasis, Cutaneous - diagnosis</subject><subject>Leishmaniasis, Cutaneous - drug therapy</subject><subject>Leishmaniasis, Visceral - diagnosis</subject><subject>Leishmaniasis, Visceral - drug therapy</subject><subject>Miltefosine</subject><subject>Phosphorylcholine - therapeutic use</subject><subject>Vector-borne diseases</subject><issn>1195-1982</issn><issn>1708-8305</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2022</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><sourceid>BENPR</sourceid><recordid>eNp9kUtrHDEQhEVIiF855R4EgWAIY-sx0khHY5LYsGAfHF-H3lUr1npGs5Y0MfGvt8JufMjBpy6aj6KoIuQjZyecWXm6LuNpAVhybd-Qfd4x0xjJ1NuquVUNt0bskYOc14wxYYR4T_Zkq7VRyuyTdD3l0tzDAA08QaIO0wgDHTDkuxFigBwydTPSMtHFy5OG6CGWeayCQqQXl7dNxF9Qwm-km3owFloSQkFHH0O5o2MYCvoph4hH5J2HIeOH3T0kP79_uzm_aBZXPy7PzxbNShpVGi0ZSMvbpTMCbeu1YEvdtYbbjknHney0kyi0xw6FZ0pbBY559Na3THEtD8nx1neTpocZc-nHkFc4DBBxmnMvlGlZLc2qin7-D11Pc4o1XV8bq3E0k6JSX7fUKk05J_T9JoUR0p-es_7vFH2dot9NUelPO895OaJ7Yf91X4EvW2CaN686PQPLwJKx</recordid><startdate>20221104</startdate><enddate>20221104</enddate><creator>Monge-Maillo, Begoña</creator><creator>Norman, Francesca F</creator><creator>Chamorro-Tojeiro, Sandra</creator><creator>Gioia, Francesca</creator><creator>Pérez-Molina, José-Antonio</creator><creator>Chicharro, Carmen</creator><creator>Moreno, Javier</creator><creator>López-Vélez, Rogelio</creator><general>Oxford University Press</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7RV</scope><scope>7T5</scope><scope>7X7</scope><scope>7XB</scope><scope>88E</scope><scope>8C1</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>8FQ</scope><scope>8FV</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>BENPR</scope><scope>CCPQU</scope><scope>DWQXO</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>H94</scope><scope>K9.</scope><scope>KB0</scope><scope>M0S</scope><scope>M1P</scope><scope>M3G</scope><scope>NAPCQ</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>Q9U</scope><scope>7X8</scope><orcidid>https://orcid.org/0000-0003-0960-1630</orcidid><orcidid>https://orcid.org/0000-0003-0336-7767</orcidid></search><sort><creationdate>20221104</creationdate><title>Post-kala-azar dermal leishmaniasis due to Leishmania infantum in an HIV-negative patient treated with miltefosine</title><author>Monge-Maillo, Begoña ; Norman, Francesca F ; Chamorro-Tojeiro, Sandra ; Gioia, Francesca ; Pérez-Molina, José-Antonio ; Chicharro, Carmen ; Moreno, Javier ; López-Vélez, Rogelio</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c385t-630a3914bd82e94f620b674819703d1d376d3e26fe7e2f05695ad0fef9f405163</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2022</creationdate><topic>Antifungal agents</topic><topic>Antiprotozoal Agents - therapeutic use</topic><topic>Case reports</topic><topic>Diabetes</topic><topic>HIV</topic><topic>HIV Infections - complications</topic><topic>HIV Infections - drug therapy</topic><topic>Human immunodeficiency virus</topic><topic>Humans</topic><topic>Immunosuppression</topic><topic>Leishmania infantum</topic><topic>Leishmaniasis</topic><topic>Leishmaniasis, Cutaneous - diagnosis</topic><topic>Leishmaniasis, Cutaneous - drug therapy</topic><topic>Leishmaniasis, Visceral - diagnosis</topic><topic>Leishmaniasis, Visceral - drug therapy</topic><topic>Miltefosine</topic><topic>Phosphorylcholine - therapeutic use</topic><topic>Vector-borne diseases</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Monge-Maillo, Begoña</creatorcontrib><creatorcontrib>Norman, Francesca F</creatorcontrib><creatorcontrib>Chamorro-Tojeiro, Sandra</creatorcontrib><creatorcontrib>Gioia, Francesca</creatorcontrib><creatorcontrib>Pérez-Molina, José-Antonio</creatorcontrib><creatorcontrib>Chicharro, Carmen</creatorcontrib><creatorcontrib>Moreno, Javier</creatorcontrib><creatorcontrib>López-Vélez, Rogelio</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>Nursing & Allied Health Database</collection><collection>Immunology Abstracts</collection><collection>Health & Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Medical Database (Alumni Edition)</collection><collection>Public Health Database</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>Canadian Business & Current Affairs Database</collection><collection>Canadian Business & Current Affairs Database (Alumni Edition)</collection><collection>ProQuest Central (Alumni Edition)</collection><collection>ProQuest Central UK/Ireland</collection><collection>ProQuest Central</collection><collection>ProQuest One Community College</collection><collection>ProQuest Central Korea</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>AIDS and Cancer Research Abstracts</collection><collection>ProQuest Health & Medical Complete (Alumni)</collection><collection>Nursing & Allied Health Database (Alumni Edition)</collection><collection>Health & Medical Collection (Alumni Edition)</collection><collection>Medical Database</collection><collection>CBCA Reference & Current Events</collection><collection>Nursing & Allied Health Premium</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central Basic</collection><collection>MEDLINE - Academic</collection><jtitle>Journal of travel medicine</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Monge-Maillo, Begoña</au><au>Norman, Francesca F</au><au>Chamorro-Tojeiro, Sandra</au><au>Gioia, Francesca</au><au>Pérez-Molina, José-Antonio</au><au>Chicharro, Carmen</au><au>Moreno, Javier</au><au>López-Vélez, Rogelio</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Post-kala-azar dermal leishmaniasis due to Leishmania infantum in an HIV-negative patient treated with miltefosine</atitle><jtitle>Journal of travel medicine</jtitle><addtitle>J Travel Med</addtitle><date>2022-11-04</date><risdate>2022</risdate><volume>29</volume><issue>7</issue><issn>1195-1982</issn><eissn>1708-8305</eissn><abstract>Post-kala-azar dermal leishmaniasis due to Leishmania infantum in an HIV-negative patient is very infrequent and this case highlights how it can be associated to other types of immunosuppression. Moreover, this case reports an effective therapeutic option with miltefosine, which can be very useful due to the scarce experience reported.</abstract><cop>England</cop><pub>Oxford University Press</pub><pmid>34668558</pmid><doi>10.1093/jtm/taab169</doi><orcidid>https://orcid.org/0000-0003-0960-1630</orcidid><orcidid>https://orcid.org/0000-0003-0336-7767</orcidid><oa>free_for_read</oa></addata></record> |
fulltext | fulltext |
identifier | ISSN: 1195-1982 |
ispartof | Journal of travel medicine, 2022-11, Vol.29 (7) |
issn | 1195-1982 1708-8305 |
language | eng |
recordid | cdi_proquest_miscellaneous_2584016995 |
source | Oxford University Press Journals All Titles (1996-Current); MEDLINE; Alma/SFX Local Collection |
subjects | Antifungal agents Antiprotozoal Agents - therapeutic use Case reports Diabetes HIV HIV Infections - complications HIV Infections - drug therapy Human immunodeficiency virus Humans Immunosuppression Leishmania infantum Leishmaniasis Leishmaniasis, Cutaneous - diagnosis Leishmaniasis, Cutaneous - drug therapy Leishmaniasis, Visceral - diagnosis Leishmaniasis, Visceral - drug therapy Miltefosine Phosphorylcholine - therapeutic use Vector-borne diseases |
title | Post-kala-azar dermal leishmaniasis due to Leishmania infantum in an HIV-negative patient treated with miltefosine |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-28T16%3A22%3A35IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Post-kala-azar%20dermal%20leishmaniasis%20due%20to%20Leishmania%20infantum%20in%20an%20HIV-negative%20patient%20treated%20with%20miltefosine&rft.jtitle=Journal%20of%20travel%20medicine&rft.au=Monge-Maillo,%20Bego%C3%B1a&rft.date=2022-11-04&rft.volume=29&rft.issue=7&rft.issn=1195-1982&rft.eissn=1708-8305&rft_id=info:doi/10.1093/jtm/taab169&rft_dat=%3Cproquest_cross%3E2823856032%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2823856032&rft_id=info:pmid/34668558&rft_oup_id=10.1093/jtm/taab169&rfr_iscdi=true |